Monday, February 11, 2013
FDA and Nanotechnology Regulation
FDA and Nanotechnology Regulation - Emerging technologies bring with them concerns and uncertainties about how they should be regulated. There are many critical issues facing regulatory agencies globally. For over a decade, this challenge has continued to haunt the US Food and Drug Administration (FDA) as it struggles to handle the issue of nanogovernance. The “ baby steps ” this federal agency has taken over the past decade are generally inadequate and have contributed to regulatory uncertainty.